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Proper mitochondrial function requires the coordinated
expression of two genomes. Although nuclear genes encode for
roughly 99% of the mitochondrial proteome, the mitochondrial
genome encodes several essential inner membrane proteins of
the respiratory chain (1–4). Mitochondrial gene transcription,
translation, and membrane insertion machinery are coupled
and colocalized adjacent to the matrix surface of the inner
membrane (3). Expression is predominantly controlled by a set
of gene-specific translational activators, which cooperate to
deliver specific mRNA transcripts to the mitoribosomes (5).
Mitochondrial ribosomes are highly specialized for translating the small set of highly hydrophobic membrane proteins
encoded by mtDNA. Recent high-resolution structural analyses of human and yeast mitoribosomes have revealed major
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structural and functional differences from bacterial and
eukaryotic ribosomes (6 –12). These differences include: 1) the
5S rRNA of the large subunit (mtLSU)2 has been lost, resulting
in a remodeled central protuberance (CP) region. 2) Mitoribosomes have incorporated additional proteins resulting in an
increased protein to rRNA ratio. 3) Hydrophobic residues line
the walls of the polypeptide tunnel exit (PTE), which presumably slows protein synthesis to facilitate cotranslational membrane insertion and assembly.
Recent knowledge has emphasized the biomedical importance of understanding the structure and assembly of mitoribosomes. Importantly, mutations in mitoribosomal proteins
(MRPs), rRNAs, and assembly factors are responsible for a
growing number of severe human disorders. These include a
heterogeneous group of infantile multisystemic OXPHOS diseases such as sensorineural hearing loss, hypertrophic cardiomyopathy, Leigh’s syndrome, and encephalomyopathy (13).
In addition, mitoribosomes and their accessory proteins are
increasingly being recognized as cancer biomarkers and targets
for cancer therapy (14, 15). Furthermore, mitoribosomes are
the unintended target of clinically important antibiotics used to
treat bacterial infections, which can produce deleterious side
effects (16, 17). For these reasons, it is important to understand
how mitochondrial ribosomes are assembled.
Mitoribosome biogenesis is a remarkably complex process
that requires coordinated expression of mtDNA-encoded
rRNAs with nuclear-encoded chaperones, assembly factors,
and MRPs. Although recent studies have provided a general
framework for the order in which MRPs are assembled in the
mtLSU, the details remain largely unknown (18, 19). Ten
assembly factors have been reported thus far in Saccharomyces
cerevisiae and can be classified as rRNA-modifying enzymes,
MRP-processing enzymes, GTPases, and RNA helicases (13–
15, 20). Surprisingly, proteins that bind and chaperone newlyimported MRPs during assembly have not been reported. This
class of proteins is important because the long unstructured
domains and high basic amino acid content of MRPs makes
them particularly vulnerable to misfolding and aggregation.
Here, we report that an evolutionarily conserved mitochondrial acidic matrix protein called Mam33 chaperones newly2

The abbreviations used are: mtLSU, mitochondrial large subunit; CP, central
protuberance; PTE, polypeptide tunnel exit; qRT, quantitative RT; DDM,
n-dodecyl ␤-D-maltoside; SILAC, stable isotope labeling by amino acids in
cell culture; MTS, mitochondrial targeting signal; GST, glutathione S-transferase; ␤-ME, ␤-mercaptoethanol; PMSF, phenylmethylsulfonyl fluoride;
Ni-NTA, nickel-nitrilotriacetic acid.
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Mitochondrial ribosomes are functionally specialized for the
synthesis of several essential inner membrane proteins of the
respiratory chain. Although remarkable progress has been made
toward understanding the structure of mitoribosomes, the pathways and factors that facilitate their biogenesis remain largely
unknown. The long unstructured domains of unassembled ribosomal proteins are highly prone to misfolding and often require
dedicated chaperones to prevent aggregation. To date, chaperones that ensure safe delivery to the assembling ribosome have
not been identified in the mitochondrion. In this study, a respiratory synthetic lethality screen revealed a role for an evolutionarily conserved mitochondrial matrix protein called Mam33 in
Saccharomyces cerevisiae mitoribosome biogenesis. We found
that the absence of Mam33 results in misassembled, aggregated
ribosomes and a respiratory lethal phenotype in combination
with other ribosome-assembly mutants. Using sucrose gradient
sedimentation, native affinity purifications, in vitro binding
assays, and SILAC-based quantitative proteomics, we found
that Mam33 does not associate with the mature mitoribosome,
but directly binds a subset of unassembled large subunit proteins. Based on these data, we propose that Mam33 binds specific mitoribosomal proteins to ensure proper assembly.

Mam33 functions in mitoribosome biogenesis

Results
Point mutations in genes necessary for mitochondrial
translation are respiratory synthetic lethal with mam33⌬
We previously reported that in the absence of Mam33, Cox1
translation is impaired, and cells poorly adapt to respiratory
conditions because they lack basal fermentative levels of Cox1
(33). Given that these cells still respire normally, we reasoned
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that this fermentation-specific phenotype could be explained
by a redundant pathway that functions during respiration. To
identify the components of this pathway, we utilized the phenomenon of respiratory synthetic lethality. This approach
assumes that if an alternate pathway compensates for Mam33
during respiration, then mam33⌬ cells bearing a mutation in
this second pathway will fail to respire. Additionally, mutations
that are respiratory lethal in combination with mam33⌬ might
reveal factors that regulate the same process as Mam33.
To identify respiratory synthetic lethal mutants, chemically
mutagenized clones of mam33⌬ cells were screened for the
inability to respire following the loss of a plasmid containing
WT MAM33 using an ADE3/ade2/ade3-based colony-sectoring assay (34 –36). Three recessive mutants that fulfilled the
criteria of being respiratory synthetically lethal with mam33⌬
were divided into two complementation groups, and the corresponding WT genes were cloned from a genomic library. From
this screen, we identified three alleles in two different genes that
are respiratory synthetic lethal in combination with mam33⌬:
mrh4-1, mrpl4-1, and mrpl4-2 (Fig. 1).
Interestingly, Mrh4 and MrpL4 are directly associated with
the mitochondrial translation machinery. Mrh4 is a mitochondrial DEAD-box RNA helicase that is essential for mtLSU
assembly (37, 38). This protein has several conserved domains
and motifs that are typical of DEAD-box RNA helicases: a
DEAD-box motif (Asp-Glu-Ala-Asp), an ATP- binding
domain, and four RNA-binding motifs (39, 40). The mrh4-1
allele identified in this study encodes a protein with a single
amino acid substitution (P209L) within the first RNA-binding
motif (Fig. 1A). The second protein, MrpL4 (uL29), is a mtLSU
PTE protein that is positioned in close proximity to the cotranslational membrane insertion machinery (6, 8, 41– 43). The
mrpl4-1 and mrpl4-2 alleles identified in this study result in
E260K and P67L amino acid substitutions, respectively (Fig.
1B).
Given that cells require Mam33 to adapt efficiently from fermentative to respiratory carbon sources (33), we asked whether
cells harboring any of the respiratory synthetic lethal alleles
alone also had difficulty adapting to respiratory media. To
test this possibility, serial dilutions of fermenting exponential
phase cells were spotted onto plates containing glucose or nonfermentable carbon sources. Although the mrpl4-2 mutant
formed colonies indistinguishable from WT on respiratory
medium, the mrh4-1 mutant adapted slower than mam33⌬
cells (Fig. S1A). None of the mutations compromised the reverse
shift, from respiratory to fermentative growth. Increased adaptation time for a cell culture population could result from some
cells being unable to adapt, all cells adapting slowly, or a combination of both. To assay cell viability following adaptation,
fermenting exponential-phase cells were spread for single colonies on plates containing either glucose or nonfermentable
carbon sources, and the number of colonies was compared. We
found that only about 3% of mrh4-1 cells were able to adapt
compared with WT cells (Fig. S1B). This result demonstrates
that mrh4-1 mutants have a more severe adaptation defect than
previously observed for mam33⌬ cells (33).
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imported MRPs prior to their incorporation into the assembling ribosome. The broad clinical significance of this finding is
emphasized by the ubiquitous nature of the mammalian
ortholog p32/HABP1/gC1qR and its implications in cancer
progression and mitochondrial disease (21). p32 is a multicompartmental protein with established roles in immunological
response, cell cycle regulation, apoptosis, nuclear transcription,
splicing, sperm-oocyte interactions, and respiratory chain biogenesis. Importantly, overexpression of p32 has been detected
in nearly all tissue-specific forms of cancer and is correlated
with poor prognosis in patients.
Despite its diverse cellular functions, p32 primarily localizes
to the mitochondrial matrix in most cell types, and mutations
or changes in its expression ultimately result in mitochondrial
dysfunction (22–25). In normal fibroblasts, p32 overexpression
results in ROS generation, increased Ca2⫹ uptake, loss of membrane potential, and the subsequent induction of apoptosis
(26 –28). In contrast, homozygous disruption of the p32
ortholog in mice leads to mid-gestation lethality (25). In human
patients, bi-allelic mutations cause severe multisystemic
defects in mitochondrial energy metabolism (25, 29). Given
that p32 has been the subject of more than 150 reports and the
accumulating evidence for its involvement in human disease, it
is surprising that its precise mitochondrial function remains
unknown.
Studies in mammals suggest that the function of p32 is conserved in other eukaryotes. Crystal structures show that the
mammalian, fungal, and protozoan orthologs all form a
homotrimeric doughnut-shaped protein, with a peculiar acidic
face (30 –32). The introduction of p32 can restore the respiratory growth impairment in yeast cells lacking Mam33 (23). Furthermore, the mtDNA instability and reduced mitochondrial
gene expression observed in mice and human patients with disrupted p32 are reminiscent of yeast mitochondrial translation
mutants (25, 29). We chose to study this protein in yeast
because it is the only model organism with established techniques to genetically manipulate mtDNA and does not require
a functional respiratory chain for viability.
We previously reported that Mam33 promotes the translation of mtDNA-encoded Cox1, the core catalytic subunit that
nucleates the assembly of cytochrome c oxidase (33). Mam33 is
not required for exponential-phase respiratory growth, but
rather to efficiently adapt from fermentation to respiration,
suggesting that a second factor compensates for Mam33 activity during respiration in yeast. In our present study, we sought
to find proteins functionally redundant with Mam33 during
respiration. Interestingly, the proteins identified were also necessary for Cox1 translation, and suggested a role for Mam33 in
mitoribosome assembly.

Mam33 functions in mitoribosome biogenesis

Mrh4 is necessary for Cox1 translation during fermentative
growth
Cox1 translation is impaired in mam33⌬ cells during fermentative conditions (33), we speculated this might account for
the synthetic respiration defect observed in mam33⌬ mrh4-1
double mutants. To test this possibility, mitochondrial translation was monitored in vivo by pulse-labeling cells with [35S]methionine and cysteine while blocking cytosolic protein synthesis
with cycloheximide. In S. cerevisiae, the mitoribosomes synthesize eight proteins including three cytochrome c oxidase subunits (Cox1, Cox2, Cox3), one apocytochrome b subunit (Cob),
three F1F0-ATP synthase subunits (Atp6, Atp8, Atp9), and a
ribosomal small subunit protein (Var1) (2, 3). The mam33⌬
mrh4-1 allele combination led to mtDNA instability (⫺) and as
a result, no mitochondrial translation products were produced
(Fig. 2A). This phenotype is common in mutants defective in
mitochondrial translation and has previously been observed in
mrh4⌬ cells (37, 44). However, the mtDNA remained stable
in cells containing the mrh4 –1 allele alone (84% ⫹) and the
translational profile of these cells resembled that observed for

the mam33⌬ strain. Cox1 synthesis was strongly diminished
during fermentation, whereas Cox2 and Cox3 were reduced to
a lesser extent, suggesting an indirect effect. In contrast, respiring cells produced all three Cox proteins at WT levels (Fig. 2B).
Given that mam33⌬ mrh4-1 cells are unable to respire, this
latter result is consistent with the idea that Mam33 and Mrh4
are functionally related.
We next asked whether the reduction of Cox1 protein synthesis in mrh4-1 mutants results from transcription, mRNA
stability, or splicing defects. Total transcript levels were measured by qRT-PCR using primers within COX1 exon 4, a region
present in all intermediate and mature transcripts. COX1
mRNA levels in the mrh4-1 mutant were comparable with WT,
demonstrating that reduced mRNA levels are not responsible
for the Cox1 translation defect (Fig. 2D). Because COX1 contains up to seven introns, we next considered the possibility that
reduced Cox1 translation in mrh4-1 cells results from splicing
defects. Mature transcript levels were measured by qRT-PCR
using primers spanning COX1 exon junctions. If splicing were
impaired, large introns would remain within the cDNA ampliJ. Biol. Chem. (2019) 294(25) 9813–9829
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Figure 1. Point mutations in genes necessary for mitochondrial translation are respiratory synthetic lethal with mam33⌬. A, Mrh4 and its human
ortholog DDX28 contain conserved sequence motifs typical of DEAD-box RNA helicases. A single amino acid substitution in an RNA-binding domain produces
a respiratory synthetic lethal phenotype in mam33⌬ cells (shown in red). B, MrpL4 contains a conserved sequence domain of the MrpL47 superfamily. The two
amino acid substitutions obtained from the mam33⌬ respiratory synthetic lethal screen (shown in red). C, mutations in MRH4 and MRPL4 are respiratory
synthetic lethal in combination with mam33⌬. Cells were streaked onto SC plates containing fermentable (glucose) or respiratory (glycerol ⫹ ethanol) carbon
sources and incubated at 30 °C for 2 or 4 days, respectively.

Mam33 functions in mitoribosome biogenesis

con, preventing PCR amplification. The relative abundance of
spliced transcripts was normal in mrh4-1 cells indicating efficient splicing (Fig. 2D). As a second approach to monitor splicing, Cox1 translation was evaluated in a strain carrying intronless mtDNA. Although Cox1 synthesis was mildly restored in
this strain, band intensity was still well below WT levels (Fig.
2C). Although this result suggests that MRH4 is required for
optimal COX1 intron splicing, the defect is likely indirect due to
impaired translation. This interpretation is consistent with the
observation that splicing of the first two COX1 introns is most
sensitive to a translation block (45).
Because the insertion of Cox1 into the mitochondrial inner
membrane nucleates the assembly of cytochrome c oxidase,
Cox1-specific translation defects can destabilize other complex
subunits (46, 47). To distinguish between translation and protein stability in mrh4-1 cells, we utilized mitochondrial reporter
strains in which ARG8, which encodes a mitochondrial protein
required for arginine biosynthesis, is placed under the control
of the COX1 or COX3 UTRs (Fig. 2E). These gene constructs
support growth on minimal glucose medium lacking arginine.
Introduction of the mrh4-1 mutation produced an Arg⫺
growth phenotype in cox1⌬ARG8m cells, indicating that protein synthesis is impaired in these cells. We also observed a mild
growth defect in the cox3⌬ARG8m background, consistent with
the weak Cox3 in vivo translation defect (Fig. 2A). These results
indicate that mrh4-1 cells have a specific defect in Cox1 synthesis, but not stability.
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The mrpl4 mutations intensify the Cox1 translation defect in
mam33⌬ cells
The two mrpl4 alleles that produced a respiration-deficient
phenotype in mam33⌬ cells were characterized as described for
the mrh4-1 mutant. Interestingly, the mrpl4 mutations alone
did not impair mitochondrial translation during either fermentative or respiratory growth (Figs. 3, A and C). However,
Cox1 translation was completely abolished in fermenting
mrpl4 mam33⌬ double mutants. This was not due to defects in
either COX1 mRNA transcription or stability, as judged by
qRT-PCR using primers within exon 4 (Fig. 3B). We next measured spliced COX1 transcripts using primers spanning exon
junctions. Although a ⬃60% decrease was observed in splicing
of the first three introns, translation was not restored in the
strain carrying intronless mtDNA (Fig. 3D). These results indicate that the decrease in protein synthesis cannot be attributed
to impaired splicing.
Since MrpL4 is located at the PTE in close proximity to the
membrane insertion machinery, we tested whether decreased
Cox1 translation results from a membrane insertion or assembly defect (6, 8, 41– 43). In a negative-feedback mechanism that
coordinates Cox1 protein synthesis with assembly, the translational activator Mss51 binds the nascent Cox1 polypeptide and
is released at a point late in cytochrome c oxidase assembly
(48 –56). If assembly is compromised, Mss51 remains sequestered with the misassembled complex and is unable to reinitiate
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Figure 2. Mrh4 is necessary for Cox1 translation during fermentative growth. A–C, mitochondrial translation profiles of cells grown to mid-log in galactose
(A and C) or lactate (B) and pulse-labeled with [35S]methionine and cysteine in the presence of cycloheximide. Proteins were resolved by SDS-PAGE and
visualized by autoradiography. Protein molecular masses are indicated in kilodaltons on the right. Atp8 and Atp9 run well below the smallest protein marker
(11 kDa), whose position is not indicated. D, qRT-PCR analysis of total COX1 transcript levels and specific COX1 splicing intermediates in cells fermenting
galactose. The qRT-PCR amplicons examined are indicated in the diagram above the graph. Each target was normalized to ACT1 and WT was set equal to 1
(dashed line). Bars represent the average fold-change of three biological replicates (black dots) and error bars represent S.E. E, growth phenotypes of strains
carrying an ARG8m reporter under control of the COX1 or COX3 UTRs. Cells grown to mid-log in rich glucose medium were washed twice with dH2O and 1/8
dilutions were spotted onto media containing (⫹Arg) or lacking (⫺Arg) arginine. Relevant nuclear and mitochondrial genotypes are indicated on the left and
right side of the panel, respectively.

Mam33 functions in mitoribosome biogenesis

Cox1 synthesis. This negative-feedback mechanism can be
bypassed by using a truncated version of Cox1 (Cox1⌬C15) that
is unable to bind Mss51 (54). This allele leaves Mss51 constitutively available to activate Cox1 synthesis, which eliminates
feedback in various Cox1 assembly mutants. In the mrpl4
mam33⌬ double mutants, the Cox1⌬C15 allele did not restore
Cox1 synthesis, whereas translation in the pet100⌬ assembly
mutant control was significantly restored (Fig. 3E). This result
indicates that the Cox1 translation defect in the mrpl4

mam33⌬ double mutant does not indirectly result from complex assembly defects.
To determine whether the translation defect in mrpl4
mam33⌬ double mutant results from protein instability,
translation was measured using the cox1⌬::ARG8m and
cox3⌬::ARG8m reporters (Fig. 3F). Because mrpl4-1 mam33⌬
double mutants displayed significant genome instability (40%
⫹), this experiment was only performed with the mrpl4-2
allele (98% ⫹; Fig. 3A). Furthermore, because the mam33⌬
J. Biol. Chem. (2019) 294(25) 9813–9829
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Figure 3. The mrpl4 mutations intensify the Cox1 translation defect in mam33⌬ cells. A, mitochondrial translation profiles of cells grown to mid-log in
galactose and pulse-labeled with [35S]methionine and cysteine in the presence of cycloheximide. Proteins were resolved by SDS-PAGE and visualized by
autoradiography. Protein molecular masses are indicated in kilodaltons on the right. Atp8 and Atp9 run well below the smallest protein marker (11 kDa), whose
position is not indicated. B, qRT-PCR analysis of total COX1 transcript levels and specific COX1 splicing intermediates in cells fermenting galactose. The qRT-PCR
amplicons examined are indicated in the diagram above the graph. Each target was normalized to ACT1 and WT was set equal to 1 (dashed line). Bars represent
the average fold-change of three biological replicates (black dots) and error bars represent S.E. C–E, experiment performed as described in A, except that cells
in C, were grown in lactate. The WT (MRPL4) lane in C is duplicated from Fig. 2B (labeled MRH4). In both figures, WT and mutant cells were grown identically,
simultaneously labeled, and loaded on the same gel. The WT sample was loaded between the mrpl4 and mrh4 mutant samples to serve as a control for both
experiments. Protein molecular masses are indicated in kilodaltons on the right. Atp8 and Atp9 run well below the smallest protein marker (11 kDa), whose
position is not indicated. F, growth phenotypes of strains carrying an ARG8m reporter under control of the COX1 or COX3 UTRs. Cells grown to mid-log in rich
glucose medium were washed twice with dH2O and 1/8 dilutions were spotted onto media containing (⫹Arg) or lacking (⫺Arg) arginine. Plates were
incubated at 30 °C for the time indicated below each panel.

Mam33 functions in mitoribosome biogenesis

mutation alone produces an Arg⫺ phenotype, incubation at
30 °C was extended to better distinguish between the single and
double mutants. Following extended incubation, mam33⌬ cells
grew slowly on Arg⫺ medium, whereas the mrpl4-2 mam33⌬
double mutant maintained an Arg⫺ growth phenotype. In contrast, expression of the cox3⌬::ARG8m reporter was unaffected
by the mrpl4-2 mutation.
Taken together, it appears that there is a specific defect
in the translation of Cox1 in mrpl4 mam33⌬ double
mutants. This phenotype was more severe than in mam33⌬
single mutants, which may explain the synthetic respiratory
defects.
Mam33 interacts with a subset of unassembled mtLSU
proteins, but not mature mitoribosomes
Given that Mam33 is necessary for optimal mitochondrial
translation and functionally interacts with two proteins
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directly involved in protein synthesis, we explored the possibility that Mam33 might associate with mitoribosomes. To
answer this question, we assessed whether Mam33 and mitoribosomes cosediment in sucrose gradients. WT mitochondria were solubilized with the nonionic detergent n-dodecyl
␤-D-maltoside (DDM) in the presence of low (25 mM KOAc)
or high (300 mM KOAc) salt concentrations to favor either
monosomes or individual subunits, respectively. Mam33
remained in the top fractions of the gradient under both salt
conditions and did not sediment with either the monosome
or the individual subunits (Fig. 4A). Although sucrose gradient sedimentation analysis has successfully been used to
detect physical interactions with the ribosome, this result
does not conclusively demonstrate that Mam33 does not
bind the mature ribosome as actively translating ribosomes
are disrupted upon solubilization (37, 57, 58).
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Figure 4. Mam33 interacts with a subset of unassembled mtLSU proteins, but not mature mitoribosomes. A, sucrose gradient sedimentation
analysis of Mam33 and ribosomal subunits in mitochondrial extracts prepared from WT cells grown in rich galactose medium. Mitochondria were
solubilized under the indicated magnesium and salt conditions, and gradients were centrifuged for 2 (high salt) or 3 (low salt) h. Twelve equal fractions
were analyzed by Western blotting using the indicated antibodies. Protein molecular masses are indicated in kilodaltons on the left. B, mitochondria
isolated from respiring (Gly, Lac) or fermenting (Gal) cells expressing either WT (⫺) or 8⫻His-tagged (⫹) Mam33 were solubilized and 8⫻His-Mam33 was
purified by metal affinity chromatography. Eluted proteins were resolved by SDS-PAGE and visualized with silver stain. Indicated bands were excised
and sent for identification by MS. Protein molecular masses are indicated in kilodaltons on the left. C, mitochondria isolated from fermenting (Gal) cells
expressing either WT (⫺) or 3⫻Myc-tagged (⫹) Mam33 were solubilized and 3⫻Myc-Mam33 was purified by using anti-myc–agarose beads. Eluted
proteins were resolved by SDS-PAGE and visualized with silver stain. Protein molecular masses are indicated in kilodaltons on the left. D, experiment
performed as described in B, comparing ⫹ and o cells. E, list of identified protein bands from B to D. Also, see Table S6. F, Mam33 copurifies with
proteins in specific regions of the ribosome. Crystal structure of the yeast mtLSU. Proteins that copurified with Mam33 are colored, whereas all others
are shown in gray. Also, see Fig. S3.

Mam33 functions in mitoribosome biogenesis

Mam33 directly interacts with individual mtLSU proteins
in vitro
To determine which MRPs directly interact with Mam33,
candidate proteins were individually tested for their ability to
copurify with Mam33. Each MRP tested was translated in either
rabbit reticulocyte lysates or wheat germ extracts supplemented with [35S]methionine and recombinant 6⫻His-Mam33
(Fig. 5A). Full-length radiolabeled polypeptides were obtained
for all MRPs except MrpL40 (uL24), which was synthesized as
several truncated products (Fig. 5B). Following expression,
6⫻His-Mam33 was affinity purified from each reaction and
copurifying MRPs were visualized by autoradiography and
quantified by scintillation counting (Fig. 5, C and D). Mam33
directly interacted with RmL2 (uL2), Mrp7 (bL27), MrpL10
(uL15), MrpL27 (mL41), MrpL32 (bL32), and MrpL49 (bL21).
Although this experiment does not definitively exclude the

remaining MRPs as binding partners, it demonstrates that
Mam33 is capable of directly binding individual unassembled
MRPs.
Mam33, MrpL4, and Mrh4 are necessary for proper assembly
of the mtLSU
Given that Mam33 physically interacts with specific unassembled MRPs, we hypothesized that it might be necessary for
mitoribosome biogenesis. Likewise, this process might also be
disrupted in the mrpl4 and mrh4 respiratory synthetic lethal
mutants identified in this study. To assess mitoribosome
integrity, we analyzed the sedimentation patterns of MRPs in
sucrose gradients, using either low (100 mM KOAc) or high (300
mM KOAc) salt conditions. Although low salt conditions were
useful for visualizing general assembly defects and aggregation,
stringent salt conditions were ideal for visualizing the specific
defects described below because they favored dissociation of
the ribosome into its individual subunits, partially disrupted
protein/rRNA aggregates, and destabilized weak interactions to
reduce smearing through the gradient. Fractions of the gradient
were analyzed for rRNA content and a representative set of
MRPs by qRT-PCR and immunoblotting, respectively (Fig. 6, A
and B). In WT extracts, the small and large subunits were confined to the middle of the gradient with distinct peaks at fractions 6 and 7, respectively. The mrpl4-2 mutant exhibited
similar sedimentation patterns, consistent with its normal
translation phenotype (Fig. 3A). In contrast, MRPs in mam33⌬,
mrh4-1, and mrpl4-2 mam33⌬ mutants were found not only in
the middle of the gradient, but also in fractions of low density
and the highest density. This additional distribution likely
reflects free or partially assembled MRPs (top fractions) and
aggregates (bottom fraction). In the mrh4-1 single mutant and
mrpl4-2 mam33⌬ double mutants, the mtLSU shifted to fraction 6, indicating that many components were missing from
the large subunit. In mam33⌬ single mutants and mrpl4-2
mam33⌬ double mutants, a large percentage of 21S rRNA was
found at the bottom of the high salt gradients, suggesting the
aggregation of not just MRPs, but the assembling large subunit.
In summary, these results demonstrate that ribosome assembly
is severely impaired in these mutants.
The sucrose gradient experiments were also used to compare
the assembly of MrpL4 P67L into the mtLSU and determine
whether Mam33 impacts its insertion (Fig. 6B). Under both salt
conditions, a moderate percentage of MrpL4 shifted to the top
of the gradient in mam33⌬ and mrpl4-2 cells. However, a significant portion of the protein remained with the assembled
large subunit, consistent with their respiratory-competent phenotypes. The amount of MrpL4 P67L dissociated from the large
subunit increased substantially in the mam33 mrpl4-2 double
mutant. Taken together with the physical interaction data,
these results suggest that MrpL4 P67L is incorrectly assembled
into the ribosome. The absence of Mam33 exacerbates this
phenotype suggesting a mechanism for the respiratory lethal
interaction.
Mam33 has a minimal effect on MRP steady-state levels
Given its role in preventing misfolding and aggregation, we
next asked if Mam33 is also required to maintain MRP steadyJ. Biol. Chem. (2019) 294(25) 9813–9829
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Because Mam33 appeared to function independently of
the mitoribosome, a native affinity purification strategy was
used to identify other interacting proteins. To facilitate
Mam33 purification, an 8⫻His tag was inserted at the N terminus of the mature protein. The tagged protein was functional
and expressed at native levels (Fig. S2). Mitochondria isolated
from both respiring and fermenting cells were solubilized and
8⫻His-Mam33 was purified by metal affinity chromatography
using the high-stringency conditions employed to assess potential mitoribosome interactions. Several proteins consistently
copurified with 8⫻His-Mam33 but not the untagged control
(Fig. 4B). To demonstrate that copurification was not due to
interaction with the 8⫻His epitope tag, the experiment was
repeated using 3⫻Myc-Mam33. Although this fusion protein
was less active based on Cox1 steady-state protein levels, the
anti-Myc pulldown produced a comparable set of copurifying
proteins (Fig. 4C and Fig. S2). In addition, because 3⫻Myc- and
8⫻His-Mam33 migrate at different molecular weights, proteins that comigrated with either tagged protein could be
resolved. Copurifying proteins present in at least three biological replicates were excised and identified by LC-MS/MS (Fig.
4E). Given that Mam33 does not sediment with the mitoribosome, we were surprised to find that 16 of the 46 mtLSU proteins copurified with Mam33. Interestingly, these proteins were
generally localized to two distinct regions of the large subunit,
the CP and PTE (Fig. 4F and Fig. S4). Other less abundant interacting proteins were predominantly associated directly or indirectly with the translation machinery. Together with the
cosedimentation experiments, these protein interactions suggest that Mam33 associates with individual mtLSU proteins,
but not the fully assembled large subunit.
Based on these protein interactions, we speculated that
Mam33 might play a role in mitoribosome biogenesis and bind
unassembled MRPs prior to their assembly. To test this possibility, we repeated the 8⫻His-Mam33 pulldown experiment
with o cells, which lack mtDNA. These cells lack assembled
mitoribosomes because both rRNAs are encoded by the
mtDNA. Consistent with our hypothesis, we found that
Mam33 still interacts with MRPs in the absence of assembled
ribosomes (Fig. 4D).
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state levels. Although most MRPs remained stable, Mrp20
(uL23) was moderately decreased in mam33⌬ and mrpl4-2 single mutants, and nearly abolished in the double mutant (Fig. 7).
Because antibodies are not available for most MRPs, we used a
MS approach to detect differences in their abundances. Mitochondria were prepared from fermenting WT and mam33⌬
cells grown in parallel, except that WT proteins were labeled
with heavy isotopes of arginine and lysine. The use of these
isotopes did not noticeably alter growth rate. Light (mam33⌬)
and heavy (WT) samples were mixed at a 1:1 ratio and analyzed
using SILAC-based quantitative proteomic analysis. Consistent
with our Western blot analysis, most large and small subunit
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ribosomal proteins remained stable, whereas Mrp20 was
decreased (62% of WT; Tables S5, S9, and S10). Of the proteins
that Mam33 directly binds, only MrpL27 was destabilized in
mam33⌬ cells (mL41; 48% of WT). In addition, MrpL13 (mL50;
69% of WT) and MrpL38 (uL14; 46% of WT) were decreased.
Although MrpL13 does not appear to physically interact with
Mam33, it interacts with Mrp20. It remains unclear whether
Mam33 directly binds MrpL38, because it may have been
missed in our copurification experiments due to its small size
(⬍15 kDa). Together, these results indicate that Mam33 is necessary to prevent misfolding and aggregation but has a minimal
effect on MRP steady-state levels.
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Figure 5. Mam33 directly interacts with individual mtLSU proteins in vitro. A, workflow: candidate ribosomal proteins from the 8⫻His-Mam33 affinity purification
(Fig. 4) were expressed from a SP6 promoter in either rabbit reticulocyte lysates or wheat germ extracts containing [35S]methionine and recombinant 6⫻His-Mam33.
Following nickel purification, radiolabeled proteins were visualized by autoradiography and quantified by scintillation counting. B, full-length candidate proteins were
expressed in the cell-free transcription/translation reaction in the presence of recombinant 6⫻His-Mam33. Proteins from 1/100 of each reaction were resolved by
SDS-PAGE and radiolabeled products were visualized by autoradiography. Predicted molecular weights based on amino acid sequence are shown directly below each
lane. Protein molecular masses are indicated in kilodaltons on the left (first two panels) and right (third panel). C, several proteins synthesized in cell-free lysates copurify
with recombinant 6⫻His-Mam33. Percent copurified was calculated as cpm in the bead elution divided by cpm in a TCA precipitate of the total transcriptiontranslation reaction. Bars represent the average of at least three biological replicates minus negative control reactions lacking 6⫻His-Mam33 performed in parallel.
Error bars represent S.E. and two or three asterisks indicate p values smaller than 0.01 or 0.001, respectively (see “Experimental procedures”), for more information on
statistical analysis). Raw data are provided in Table S7. D, a fraction of the total reaction and bead eluate from the nickel-agarose beads were visualized by SDS-PAGE
and autoradiography for the six interacting proteins (Mrp7, MrpL10, RmL2, MrpL27, MrpL32, MrpL49) and one protein that did not interact (MrpL4). Protein molecular
masses are indicated in kilodaltons on the left and right of the upper and lower panel sets.
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Discussion
We recently identified an evolutionarily conserved protein
called Mam33 that promotes the translation of Cox1 in yeast
mitochondria (33). In this study, we screened for genes that
functionally compensate for Mam33 during respiration and
identified mutants with Cox1-specific translation defects and
misassembled, aggregated mitochondrial ribosomes. Interestingly, Mam33 does not associate with the assembled ribosome,
but rather binds a subset of large subunit MRPs prior to their
incorporation. Furthermore, Mam33 is necessary for proper
assembly of the large subunit. Based on these data, we propose
that Mam33 is a mitoribosome assembly factor.
In our working model, Mam33 binds newly-imported
mtLSU proteins and facilitates assembly into the large subunit
(Fig. 8). Given Mam33’s peripheral inner membrane location,
we propose that it interacts with its target during or immediately after import into the mitochondria (24). This association
may serve to maintain the extended unstructured regions of
these proteins until they can be incorporated into the large
subunit and stabilized by adjacent MRPs and rRNA. Likewise,
the acidic face of Mam33 may mask the basic regions that are
prevalent in MRPs. Another interesting possibility is that the
polypeptide passes through the central channel of the Mam33
trimer. Depending on the degree of blockage by the inner loops,
which may undergo conformational changes, the opening
would have a diameter sufficient to accommodate a polypeptide chain (31). It remains unclear whether Mam33 accompa-

Figure 6. Mam33, MrpL4, and Mrh4 are necessary for proper assembly of the mtLSU. A, sucrose gradient sedimentation analyses of the 15S and 21S rRNAs
in mam33⌬ and respiratory synthetic lethal mutants. Mitochondria isolated from cells grown in rich galactose medium were solubilized under the magnesium
and salt conditions stated, loaded on a linear 10 – 40% sucrose gradient, and centrifuged for 2 (high salt) or 3 (low salt) h. RNA purified from 12 equal gradient
fractions was analyzed by qRT-PCR using primers within the 15S or 21S rRNAs. Curves represent the amount of target rRNA in each gradient fraction divided by
the sum target rRNA in all fractions. The raw data used to create each curve is provided in Table S8. B, proteins in each gradient fraction described in A were
resolved by SDS-PAGE and mitoribosomal proteins were detected by Western blotting using antibodies recognizing a representative set of large (Mrp7,
MrpL36, MrpL4, MrpL40, Mrp20) and small (MrpS5, Nam9) subunit mitoribosomal proteins. Protein molecular masses are indicated in kilodaltons on the right.
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Figure 7. Mam33 has a minimal effect on MRP steady-state levels. Mitochondrial proteins (5 g) from cells grown in galactose were resolved by
SDS-PAGE and detected by Western blotting using the antibodies indicated
on the right side of the panel. Protein molecular masses are indicated in kilodaltons on the left.

nies its MRPs to the assembling ribosome or mediates insertion
into large subunit subassemblies.
Our Mam33 physical interaction data suggests a mechanism
responsible for the respiratory synthetic lethal interaction
between MRPL4 and MAM33. A small percentage of Mrpl4
does not sediment with the mature large subunit in either respiratory-competent single mutant (Fig. 6B). This defect was
exacerbated in the mam33⌬ mrpL4-2 double mutant, explaining the respiratory-deficient phenotype. Why does the absence
of Mam33 further impair MrpL4 P67L assembly? We have
shown that Mam33 directly binds MrpL27, which forms extensive physical contacts with MrpL4 (Fig. S3) (6, 8). Although
MrpL4 can assemble into the ribosome in the absence of
Mam33, albeit less efficiently, MrpL4 P67L cannot be incorporated. This result suggests that MrpL27 is not properly incorporated in mam33⌬ mutants. The decreased steady-state levels
of MrpL27 in mam33⌬ cells are consistent with this hypothesis
(Table S5). Furthermore, the copurification of PTE proteins
surrounding MrpL4 (MrpL40, MrpL27, MrpL13, Mhr1, and
MrpL3) with Mam33 indicates an association with this assembling subcomplex (Fig. 4).
The model that Mam33 chaperones MRPs during their
assembly is supported by the genetic relationship between
MAM33 and MRH4. The complete absence of Mrh4 results in
partially assembled ribosomes that are missing MrpL16 (uL16)
and MrpL39 (bL33), two proteins present at the interface
between the CP and the rest of the ribosome (Fig. S3B) (37). In
our mrh4-1 mutant, the CP region partially dissociated from
the large subunit. Interestingly, Mam33 copurified with several
CP proteins (Mrp7, MrpL7, MrpL17, MrpL35, MrpL36), indicating that it associates with this subassembly. Mam33 directly
interacted with Mrp7, which has a long N-terminal extension
reaching the ribosome center that appears to serve as a structural anchor for the CP. Together, these observations suggest
that the MrpL16, MrpL39, and Mrp7 anchors may not be properly incorporated in the mam33⌬ mrh4-1 double mutant, causing the CP region to completely dissociate from the ribosome.
Several lines of evidence confirm that the Mam33-mtLSU
protein interactions reported in this study are physiologically
significant. First, they are consistent with genetic data including
respiratory lethal interactions with MRH4 and MRPL4, mutant
translation phenotypes, and mtLSU assembly defects. Second,
the interactions between Mam33 and positively-charged ribosomal proteins were detected using stringent salt conditions to
prevent nonspecific electrostatic interactions. Direct binding
was observed in highly concentrated lysates containing a wide
variety of proteins to compete for binding. Moreover, interactions were only identified with a small subset of the numerous
basic proteins tested. Third, Mam33 was previously detected in
binding CP proteins in a ribosome assembly mutant using
tagged ribosomal proteins, instead of tagged Mam33 (59). This
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observation confirms that endogenous Mam33 binds unassembled ribosomal proteins. Finally, Mam33 expression correlates highly with MRPs (60). Taken together, these data support
our model that Mam33 aids in mitoribosome assembly, acting
as a chaperone for unassembled MRPs.
It is intriguing that the ribosome assembly mutants in this study
produce Cox1-specific defects rather than an overall impairment
of translation. Several mechanisms could account for this phenotype. First, Mam33, MrpL4, and Mrh4 may also function as Cox1
translational activators. Second, the ribosome defects in these
mutants may trigger regulatory signaling pathways that inhibit
Cox1 translation. Synthesis of Cox1 appears to be under the most
stringent regulation to prevent ROS formation. For instance,

mechanisms for sensing its own assembly status and heme biosynthesis have been reported (48–56). Third, Mam33, MrpL4, and
Mrh4 may be necessary for a subset of ribosomes specialized for
the synthesis of Cox1. Mitoribosomes have evolved to synthesize
the unique subset of proteins encoded by the mtDNA, but the
question remains whether different populations exist that further
specialize for particular proteins. For example, misassembled ribosomes may be missing a component dispensable for protein synthesis in general, but necessary for binding a Cox1-specific translational activator.
Why is Mam33 dispensable for respiration in yeast cells?
Given that the mammalian ortholog is essential for fetal development and specific mutations cause severe defects in mitoJ. Biol. Chem. (2019) 294(25) 9813–9829
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Figure 8. Working model for the role of Mam33 in mitoribosome biogenesis. A, structure and surface charge distribution of the Mam33 trimer (PDB 3QV0
(31)). There are three Mam33 molecules in an asymmetric unit that form a bowl- or doughnut-shaped trimer. The central channel has a diameter of ⬃15 Å.
However, the central loops that partially cover the channel reduce the diameter to about 4 Å. Electrostatic surface potential reveals an unusual asymmetric
charge distribution on the two sides of the trimer (center and right panels). Positively and negatively charged electric potential are indicated in blue and red,
respectively. B, schematic model of the role of Mam33 as a chaperone of newly-synthesized MRP’s. We propose that the Mam33 trimer physically interacts with
a specific subset of MRPs during or immediately after import into the mitochondria. This association may serve to maintain the extended unstructured regions
of these proteins until they can be incorporated into the large subunit and stabilized by adjacent MRPs and rRNA. Likewise, the acidic face of Mam33 may
stabilize the basic regions, prevalent in MRPs. Alternatively, the polypeptide may pass through the central channel of the Mam33 trimer, depending on the
degree of blockage by the inner loops. Finally, it is unclear whether Mam33 accompanies its targets to the assembling ribosome or mediates insertion into large
subunit subassemblies. In the absence of Mam33 (lower pathway), the unstructured or highly basic regions misfold and aggregate with other MRPs and the 21S
rRNA
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Experimental procedures
Strains, media, and genetic methods
Yeast strains used in this study are listed in Table S1. All
strains are congenic with either D273-10B or W303, except
MHY1934 and MHY1935, which are derived CH1304 and
CH1305. Cells were grown at 30 °C in rich medium (YP) containing 1% yeast extract and 2% peptone or minimal medium
containing 0.17% yeast nitrogen base, 0.5% ammonium sulfate,
and the appropriate amino acids, unless otherwise indicated.
Media contained 2% glucose, galactose, lactate, ethanol or 3%
glycerol, as indicated. The rich or minimal “D” medium used for
the respiratory synthetic lethal screen contained 3% glycerol,
2% ethanol, and 0.2% glucose. The mrh4-1 (c626t), mrpl4-2
(c200t), and mrpl4-1 (g778a) respiratory synthetic lethal point
mutations were re-engineered by site-directed mutagenesis
and integrated into the chromosome using the yeast integrative
vectors pRS306 (mrh4-1) or YIp5 (mrpl4-2 and mrpl4-1) (67–
69). Mam33 was tagged with 8⫻His, 1⫻Myc, or 3⫻Myc (70)
immediately downstream of the mitochondrial targeting
signal (MTS). Recombinant 6⫻His- and GST-Mam33 fusion
constructs were created by inserting MAM33⌬MTS into
the EcoRI site of pRSETA (pMHY448; Invitrogen) and pGEX4T-1 (pMHY446; Amersham Biosciences), respectively. The
sequences of these fusion proteins are provided in Table S4.
mtDNA stability was measured by growing cells to exponential
phase using conditions identical to the corresponding experiment, spreading cells for single colonies on YPD plates, and
crossing at least 50 colonies to the o tester strains. Percent of
⫹ represents the fraction of the resulting diploids that became
respiratory competent. Strains were made o by maintaining
exponential phase growth for 36 h in rich glucose medium containing 10 g/ml of ethidium bromide. Cells unable to respire
were stained with 4⬘,6-diamidino-2-phenylindole and visualized using fluorescence microscopy to confirm the complete
loss of mtDNA.
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MAM33 respiratory synthetic lethality screen
In this strategy, mam33⌬, ade2⫺, ade3⫺ cells harboring a
plasmid containing WT MAM33, a URA3 selectable marker,
and an ADE3 color marker formed red colonies, whereas those
that lost the plasmid turned white. When grown on complete
respiratory media, the red colonies contained white sectors,
these genes are not required for respiration. Following chemical mutagenesis, red nonsectoring colonies that required the
MAM33 plasmid for respiration were further analyzed as
described below.
To create the parental strain for the screen, the MAM33 ORF
in CH1305 (35) was replaced with a KANMX module from the
yeast knockout collection (71) and transformed with pMHY606
to generate MHY1935. Plasmid pMHY606 (2 M URA3 ADE3
MAM33) was generated by subcloning a 2-kb BamHI-XhoI
fragment containing MAM33 from pMHY437 (CEN URA3
MAM33) into BamHI-SalI–linearized pPS709 (72).
MHY1935 was grown in minimal glucose medium (⫺ura) to
a density of ⬃2 ⫻ 107 cells/ml, then mutagenized with EMS
to 50% killing as described previously (36). Following mutagenesis, cells were plated on rich D medium and incubated until
colonies developed a red color. Of the 225,000 colonies
screened, 359 red nonsectoring colonies were isolated and
restreaked onto fresh rich D plates. Three candidates satisfied
all the criteria for synthetic lethality with mam33⌬ on respiratory medium (36, 72)
The dominance or recessiveness of each mutant allele was
tested by mating with the unmutagenized parental strain of the
opposite mating type (MHY1934) as previously described (36).
On this basis, all mutations were judged recessive. Each resulting diploid was subsequently sporulated under conditions to
maintain plasmid pMHY606 and tetrads were scored for their
sectoring phenotypes. All mutants displayed 2:2 segregation of
the sectoring phenotype, indicating that the respiratory synthetic lethality resulted from a mutation in a single gene. Three
respiratory synthetic lethal mutants were placed into two complementation groups. Each mutant was also tested for heat
(36 °C) and cold (15 °C) sensitive phenotypes, but none showed
conditional growth phenotypes linked to the nonsectoring.
Genes complementing the respiratory synthetic lethal mutations were identified by transforming one candidate from each
complementation group, carrying only pMHY607 (CEN LEU2
ADE3 MAM33), with a YCp50-based genomic library containing a URA3 selectable marker as previously described (36, 73).
Following selection for library plasmids on minimal D medium
lacking uracil, library plasmids were isolated from white colonies, which no longer required pMHY607 to respire. The specific chromosomal regions contained within each library plasmid were determined using upstream and downstream vector
primers that flanked the insert. Sequence obtained from each
end was subsequently compared with the yeast genome database. Because each library clone insert contained more than one
gene, smaller regions were subcloned and tested individually.
RNA isolation and qRT-PCR
For RNA extraction, cells were grown to exponential phase in
rich galactose medium and RNA was isolated using RiboZol
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chondrial energy metabolism, we predict that a second protein may compensate in yeast (22, 23, 25). Although the
respiratory synthetic lethal screen was designed to identify
functionally redundant genes, it remains unclear whether
MrpL4 or Mrh4 perform the same function as Mam33 in mitoribosome assembly.
Seven chaperones have been identified in the nucleus
and cytosol of eukaryotic cells that accompany and stabilize
unassembled ribosomal proteins prior to their incorporation
into the ribosome (61, 62). Interestingly, the doughnutshaped structure and asymmetric charge distribution of one
chaperone (Sqt1) is reminiscent of Mam33 and its orthologs
(63). The acidic face stabilizes Rpl10 (uL16) by directly binding a positively charged region at the N terminus of the protein (64 –66). Although Sqt1 binds a different ribosomal protein, those chaperoned by Mam33 also contain positively
charged regions at their N terminus (Fig. S4). Future experiments aim to define the precise regions that Mam33 recognizes and to determine specifically when it binds and
releases mitoribosomal proteins.
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RNA extraction reagent (VWR) according to the manufacturer’s instructions. RNA from sucrose gradient fractions was
extracted using the Direct-zol RNA Miniprep Kit (Zymo
Research). cDNA synthesis and subsequent qRT-PCR was performed using the One-Step Real-time PCR system (Applied
Biosystems) and the Luna qRT-PCR kit (New England Biolabs)
according to the manufacturer’s recommendations. Reactions
were run in triplicate and represent the average of three biological replicates. Primer sequences are provided in Table S2.
Purification of mitochondria

Analysis of mitochondrial proteins
In vivo radiolabeling of mitochondrial translation products
and Western blotting were performed as previously described
(33, 76, 77). Western blot analysis of proteins in sucrose gradients was performed by adding an equal volume of 2⫻ SDSloading buffer directly to each gradient fraction and probing the
resulting blots with the indicated antibodies. The anti-Mam33
polyclonal antibody was obtained from Covance Inc. (Denver,
PA) by immunizing rabbits with recombinant full-length GSTMam33 purified from Escherichia coli. The anti-Cox1 mouse
mAb (11D8B7) was obtained from Abcam. The following
antibodies were gifts and used at the indicated dilutions:
anti-Mrp7 mouse mAb (1:1,000) from Tom Fox at Cornell
University (78); anti-Mrp20 mouse mAb (1:8,000) from
Carolyn Suzuki at Rutgers University (79); anti-MrpL36
(1:60,000), anti-MrpL4 (1:80,000), anti-MrpL40 (1:150,000),
and anti-MrpS5 (1:12,000) rabbit polyclonal antibodies from
Martin Ott at Stockholm University (43, 80, 81); anti-Aco1

Purification of tagged proteins
To find proteins that copurify with 8⫻His-Mam33, mitochondria (5 mg of protein) were gently resuspended in 1.5 ml of
solubilization buffer (1% DDM, 30 mM imidazole, 300 mM
KOAc, 5 mM MgOAc, 0.8 mM EDTA, 10 mM Tris-HCl, pH 7.4,
5% glycerol, 1 mM spermidine, 5 mM ␤-mercaptoethanol
(␤-ME), 1 mM PMSF, and 2.5 g/ml of pepstatin, leupeptin,
antipain, and chymostatin (PLAC)) and incubated for 15 min
with gentle rocking (all steps performed on ice or at 4 °C). Clarified lysates obtained by centrifugation at 16,000 ⫻ g for 10 min
were incubated with gentle rocking for 90 min with Ni-NTA–
agarose beads (GoldBio, catalog number H-320-35; 12 l of
slurry pre-equilibrated with solubilization buffer). The beads
were washed five times for 15 min with 1.2 ml of wash buffer
(solubilization buffer containing 0.1% DDM and 70 mM imidazole), and purified proteins were eluted with 30 l of elution
buffer (0.1% DDM, 400 mM imidazole, 100 mM NaOAc, 10 mM
Tris-HCl, pH 7.4, 5% glycerol, 5 mM ␤-ME, 0.5 mM PMSF, and
2.5 g/ml of PLAC). Eluates were diluted with 4⫻ SDS-loading
buffer and analyzed by SDS-PAGE (76). Proteins were visualized using a MS-compatible silver stain (Thermo Scientific, catalog number 24600). Bands of interest were excised and proteins were identified by NanoLC-ESI-MS/MS (ProtTech Inc.,
Phoenixville, PA).
Affinity purification of 3⫻Myc-Mam33 was performed
exactly as described for 8⫻His-Mam33, except that mitochondrial extracts were incubated with anti-myc–agarose beads
(Thermo Scientific, catalog number 20168) and proteins were
eluted with SDS-loading buffer without reducing agent. Samples were adjusted to 5% ␤-ME prior to SDS-PAGE analysis.
Recombinant 6⫻His-Mam33 was purified from E. coli
BL21(DE3) cells containing pMHY448. Cells were grown to
exponential phase (OD600 ⫽ 0.6) at 27 °C in Luria broth supplemented with 50 g/ml of carbenicillin and expression was
induced with 1 mM isopropyl 1-thio-␤-D-galactopyranoside for
3 h. The remainder of the purification was performed at 4 °C or
on ice. Cells harvested by centrifugation were resuspended in
lysis buffer (10 mM imidazole, 300 mM NaCl, 40 mM Tris-HCl,
pH 8, 5% glycerol, 5 mM ␤-ME, 1 mg/ml lysozyme, 1 mM PMSF,
2.5 g/ml of PLAC; 2 ml per 50 ml of culture), incubated on ice
for 30 min, and lysed by sonication with six 10-s pulses at a
medium setting on an ultrasonicator (Branson Sonifier 150).
The resulting lysate was supplemented with 5 g/ml of DNase I
(Sigma) and 10 g/ml of RNase A (Sigma) and incubated on ice
for 15 min. The clarified lysate obtained by 30 min centrifugation at 10,000 ⫻ g was incubated with gentle rocking for 60 min
with Ni-NTA–agarose beads (200 l slurry). Following five
15-min washes with 1.2 ml of wash buffer (60 mM imidazole,
300 mM NaCl, 40 mM Tris-HCl, pH 8, 5% glycerol, 5 mM ␤-ME,
1 mM PMSF), 6⫻His-Mam33 was eluted with 800 l of elution
J. Biol. Chem. (2019) 294(25) 9813–9829
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Exponential-phase yeast cells (OD600 ⫽ 1.0 –1.5) harvested
by centrifugation at 2,000 ⫻ g for 5 min were washed with
water, resuspended in reducing buffer (2 ml/g cells; 100 mM
Tris-SO4, pH 9.4, and 10 mM DTT), and incubated with gentle
shaking for 40 min at 30 °C. Cells were washed once with 1.2 M
sorbitol, resuspended in zymolyase buffer (6.7 ml/g of cells; 1.2
M sorbitol, 20 mM potassium Pi, pH 7.4, and zymolyase 100T
(Amsbio; 1 mg/g cells)), and incubated with gentle shaking for
40 min at 30 °C. Spheroplasts were harvested by centrifugation
at 1,500 ⫻ g for 5 min, gently resuspended in regeneration
buffer (growth media containing 1.2 M sorbitol; 6.7 ml/g of
cells), and incubated for 30 min at 30 °C with gentle shaking. All
of the subsequent steps and centrifugations were performed on
ice or at 4 °C, respectively. Regenerated spheroplasts were harvested by centrifugation at 1,500 ⫻ g for 5 min, resuspended in
SE buffer (8.5% sucrose, 10 mM MOPS-KOH, pH 7.4, 1 mM
EDTA), and homogenized by 10 strokes in a glass douncer. The
homogenate was centrifuged at 2,000 ⫻ g for 5 min and the
supernatant, containing mitochondria, was transferred to a
new tube. The pellet was rehomogenized and the supernatants
were combined. Homogenization was repeated until the cell
debris was clear and colorless (approximately four times). The
combined supernatants were centrifuged at 2,000 ⫻ g for 10
min to pellet any remaining cell debris, and mitochondria were
subsequently harvested by centrifugation at 12,000 ⫻ g for 20
min. Crude mitochondria were further purified in two consecutive sucrose gradients and protein concentrations were determined as previously described (74, 75).

(1:200,000) rabbit polyclonal antibody from Ophry Pines at
The Hebrew University of Jerusalem (82); and anti-Nam9
(1:100,000) rabbit polyclonal antibody from Godfrey Getz at
The University of Chicago (83). Blots were incubated with
horseradish peroxidase-conjugated anti-mouse or anti-rabbit
antibodies (Cell Signaling Technologies) and signals were
detected using WesternBright Sirius ECL (Advansta).
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buffer (wash buffer with 300 mM imidazole). The eluate was
concentrated in 100 mM NaCl, 40 mM Tris-HCl, pH 8, 5% glycerol using a Amicon Ultra 50,000 NMWL filter (Millipore).
Purification of recombinant GST-Mam33 was performed as
previously described (36) except that expression was induced at
25 °C for 3 h. GST-Mam33 was eluted in 20 mM GSH, 100 mM
Tris-HCl, pH 8, 120 mM NaCl and subsequently dialyzed and
stored in PBS.

or at 4 °C). Beads were subjected to five 10-min washes with 500
l of solubilization buffer containing 50 mM imidazole. 6⫻HisMam33 was eluted with 30 l of elution buffer (100 mM NaCl,
20 mM Tris-HCl, pH 7.4, 5% glycerol, 400 mM imidazole, 5 mM
␤-ME, 0.5 mM PMSF). For each eluate, 2 l was used for scintillation counting and 7.5 l was analyzed by SDS-PAGE and
autoradiography.

Sucrose gradient sedimentation

Mitochondria prepared from mam33⌬ cells (MHY2021)
were grown to mid-log (OD600 ⫽ 1.2) in minimal galactose
medium containing all amino acids. WT cells (NB40 –36a) were
grown under identical conditions, except arginine and lysine
were substituted with heavy isotopes (L-arginine-HCl (13C6),
13
L-lysine-2HCl ( C6); Thermo Scientific). SILAC-based quantitative proteomic analysis was performed by Creative Proteomics (Shirley, NY). Briefly, light (mam33⌬) and heavy (WT) purified mitochondria were mixed at a 1:1 ratio, lysates were
transferred to a Microcon device YM-10 (Millipore), centrifuged at 12,000 ⫻ g at 4 °C for 10 min, and washed twice with
200 l of 50 mM ammonium bicarbonate. The resulting sample
was reduced with 10 mM DTT at 56 °C for 1 h and then alkylated
with 20 mM indole-3-acetic acid at room temperature in the
dark for 1 h. The device was centrifuged at 12,000 ⫻ g at 4 °C for
10 min, washed once with 50 mM ammonium bicarbonate,
recentrifuged, and then 100 l of 50 mM ammonium bicarbonate was added to the protein concentrate. Free trypsin (Promega) was added a ratio of 1:50 to the protein solution, and the
solution was incubated at 37 °C overnight. The device was centrifuged at 12,000 ⫻ g at 4 °C for 10 min and washed twice with
100 l of 50 mM ammonium bicarbonate. The extracted peptides were lyophilized to near dryness and subsequently resuspended in 2–20 l of 0.1% formic acid before Nano LC-MS/MS
analysis.
Nano LC was performed using an Ultimate 3000 nano
UHPLC (Thermo Fisher Scientific, USA) with a 100 m ⫻ 10
cm in-house made nanocolumn packed with a reversed-phase
ReproSil-Pur C18-AQ resin (3 m, 120 Å, Dr. Maisch GmbH,
Germany). Mass spectrometry was performed using a Q Exactive HF mass spectrometer (Thermo Fisher Scientific, USA).
Raw MS files were analyzed and searched against the S. cerevisiae protein database based on the species of the samples using
Proteome Discoverer 2.0. The parameters were set as follows:
the protein modifications were carbamidomethylation (C)
(fixed), oxidation (M) (variable); the enzyme specificity was set
to trypsin; the maximum missed cleavages were set to 2; the
precursor ion mass tolerance was set to 10 ppm, and MS/MS
tolerance was 0.6 Da. Only high confident identified peptides
were chosen for downstream protein identification analysis.
Percentages in Tables S5, S9, and S10 represent the abundances
of light samples (mam33⌬) relative to medium samples (WT).
Note that although these data only represent one biological
replicate, it was generally consistent with other data in the
paper and therefore included for qualitative purposes.

Cell-free protein expression
To synthesize candidate proteins in vitro, we used the TNT
(rabbit reticulocyte lysate or wheat germ extract) SP6/T7 Coupled Transcription/Translation system (Promega, catalog
numbers L5020 and L5030), in the presence of L-[35S]methionine (PerkinElmer, EasyTag catalog number NEG709A). Each
gene was expressed from the PTNT vector (Promega, catalog
number L5610), containing a T7/SP6 promoter, poly(A)30 tail,
and T7 terminator. Primers were designed to amplify each gene
with an upstream XhoI or MluI restriction site, a start codon
with a Kozak consensus sequence (CCACC-ATG-GCG), the
mature coding region, and a downstream NotI restriction site.
The resulting proteins began with Met-Ala and terminated at
their natural stop codons. This expression cassette is shown in
Fig. 5A and the primers used for amplification are listed in
Table S3. Coding regions were amplified from W303 chromosomal DNA using either Q5 or Vent High-Fidelity DNA polymerases (New England Biolabs). PCR products were subsequently digested with either XhoI/Not1 or MluI/NotI, and
ligated into the pTNT vector cut with the same enzymes. Fulllength expression of Mrp7, MrpL4, MrpL40, and MrpL36 was
optimal in the rabbit reticulocyte system, whereas all others
were ideal in wheat germ extracts. SP6 was superior to T7 for
the expression of all constructs.
20 l of TNT reactions were performed according to the
manufacturer’s protocol with the addition of 1 g of purified
recombinant 6⫻His-Mam33. One-fifth of each reaction was set
aside to determine percent incorporation (as described by manufacturer), for analysis by SDS-PAGE and autoradiography.
6⫻His-Mam33 was purified by metal affinity chromatography
as follows. The remainder of the reaction was diluted with 200
l of binding buffer (150 mM KOAc, 0.5 mM MgOAc, 0.05%
DDM, 20 mM Tris-HCl, pH 7.4, 5% glycerol, 10 mM imidazole, 5
mM ␤-ME, 1 mM PMSF) and incubated with Ni-NTA beads (5
l of bead slurry) for 1 h with rocking (all steps performed on ice
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Statistical analysis
All experiments were performed at least in triplicate unless
otherwise indicated. Error bars represent mean ⫾ S.E. The sta-
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Mitochondria (2 mg of protein) were resuspended in 300 l
of solubilization buffer (1% DDM, 25–300 mM KOAc, 10 mM
Tris-HCl, pH 7.4, 0.5 mM MgOAc, 5% glycerol, 5 mM ␤-ME, 1
mM PMSF, and 2.5 g/ml of PLAC) and incubated for 15 min
with gentle rocking (all steps performed on ice or at 4 °C). Clarified lysates obtained by centrifugation at 16,000 ⫻ g for 10 min
were layered on a linear 3.6 ml of 10 – 40% sucrose gradient with
the same buffer conditions except less DDM (0.1%). Following
centrifugation at 370,000 ⫻ g (Beckman SW 60 Ti rotor; spin
time indicated for each experiment), gradients were collected
in 12 equal fractions. Proteins and mt-rRNAs were analyzed by
Western blotting or qRT-PCR as described above.

SILAC-based quantitative proteomic analysis

Mam33 functions in mitoribosome biogenesis
tistical significance in Fig. 5C was determined using an
unpaired one-tailed Student’s t test with Microsoft Excel. Significant difference in means is indicated as: **, p ⬍ 0.01 and ***,
p ⬍ 0.001.
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Software
Crystal structure images were generated using PyMOL.
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